Very Late Recurrence in Breast Cancer: Is Breast Cancer a Chronic Disease?
Although breast cancer treatments have made great strides in recent decades, there are still many recurrences. Late recurrence is one of the characteristics of breast cancer. Here, we present four cases of recurrence more than 10 years after the initial diagnosis. The time from diagnosis to recurren...
Saved in:
Published in | Curēus (Palo Alto, CA) Vol. 14; no. 3; p. e22804 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
United States
Cureus Inc
03.03.2022
Cureus |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Although breast cancer treatments have made great strides in recent decades, there are still many recurrences. Late recurrence is one of the characteristics of breast cancer. Here, we present four cases of recurrence more than 10 years after the initial diagnosis. The time from diagnosis to recurrence was 13 to 20 years in our four cases, which were all estrogen receptor (ER)-positive, and one was also human epidermal growth factor receptor 2-positive. Long-term hormone therapy for 10 years is necessary to prevent late recurrence of breast cancer, but we need to know that late recurrence remains common. Risk factors for late recurrence include ER positivity, progesterone receptor positivity, and low Ki67. The most common sites of recurrence are the lungs/pleura and bones, which was also the case in our experience. It is no exaggeration to say that breast cancer is a chronic disease similar to hypertension and diabetes. This is because breast cancer is not completely cured by surgery alone and lasts for a long time, with patients requiring long-term hormone therapy. Moreover, it can recur even after 10 years or more. |
---|---|
AbstractList | Although breast cancer treatments have made great strides in recent decades, there are still many recurrences. Late recurrence is one of the characteristics of breast cancer. Here, we present four cases of recurrence more than 10 years after the initial diagnosis. The time from diagnosis to recurrence was 13 to 20 years in our four cases, which were all estrogen receptor (ER)-positive, and one was also human epidermal growth factor receptor 2-positive. Long-term hormone therapy for 10 years is necessary to prevent late recurrence of breast cancer, but we need to know that late recurrence remains common. Risk factors for late recurrence include ER positivity, progesterone receptor positivity, and low Ki67. The most common sites of recurrence are the lungs/pleura and bones, which was also the case in our experience. It is no exaggeration to say that breast cancer is a chronic disease similar to hypertension and diabetes. This is because breast cancer is not completely cured by surgery alone and lasts for a long time, with patients requiring long-term hormone therapy. Moreover, it can recur even after 10 years or more. |
Author | Kamiyama, Koki Takasaka, Yoshihiro Kamata, Arimichi Hino, Koji |
AuthorAffiliation | 1 Surgery, Tomei Atsugi Hospital, Atsugi, JPN |
AuthorAffiliation_xml | – name: 1 Surgery, Tomei Atsugi Hospital, Atsugi, JPN |
Author_xml | – sequence: 1 givenname: Arimichi surname: Kamata fullname: Kamata, Arimichi organization: Surgery, Tomei Atsugi Hospital, Atsugi, JPN – sequence: 2 givenname: Koji surname: Hino fullname: Hino, Koji organization: Surgery, Tomei Atsugi Hospital, Atsugi, JPN – sequence: 3 givenname: Koki surname: Kamiyama fullname: Kamiyama, Koki organization: Surgery, Tomei Atsugi Hospital, Atsugi, JPN – sequence: 4 givenname: Yoshihiro surname: Takasaka fullname: Takasaka, Yoshihiro organization: Surgery, Tomei Atsugi Hospital, Atsugi, JPN |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35382184$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkN1LwzAUxYNMnM69-SwBX-3MR5M2PihavyYDQdTXkGa3rmNrZ9IK---Nbo7t6ebmHH73cI5Qp6orQOiEkkGSCHVhWwetHzCWkngPHTIq0yiladzZendR3_spIYSShJGEHKAuFzxlQTpEzx_glnhkGsCvEGgOKgu4rPCtA-MbnJmwu0s89Ls_2OBs4uqqtPiu9EGA62O0X5iZh_569tD7w_1b9hSNXh6H2c0ospyoJgoZREzyOFeFTbkCkahYwRgSYdOiSFXCOQWrZC6JsWMBsWSMWVoYMFSCUbyHrlbcRZvPYWyhapyZ6YUr58YtdW1KvatU5UR_1t86sGUseACcrQGu_mrBN3pat64KmTWTIpGcc0mD63zlsq723kGxuUCJ_i1fr8rXf-UH--l2qo35v2r-A4mngiQ |
CitedBy_id | crossref_primary_10_1007_s13691_024_00698_y |
Cites_doi | 10.1016/S0140-6736(12)61963-1 10.1200/JCO.2015.62.3504 10.1056/NEJMoa1113216 10.1002/cncr.27472 10.1200/JCO.2007.11.3787 10.1002/ijc.31914 10.4030/jjcs.39.870 10.2147/BCTT.S26431 10.1016/S0140-6736(11)60993-8 10.1002/14651858.CD006243.pub2 10.1001/jama.1994.03510440047031 10.1159/000502636 10.1001/jama.271.20.1593 10.1056/NEJMoa1703643 10.1159/000353099 |
ContentType | Journal Article |
Copyright | Copyright © 2022, Kamata et al. Copyright © 2022, Kamata et al. This work is published under https://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Copyright © 2022, Kamata et al. 2022 Kamata et al. |
Copyright_xml | – notice: Copyright © 2022, Kamata et al. – notice: Copyright © 2022, Kamata et al. This work is published under https://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Copyright © 2022, Kamata et al. 2022 Kamata et al. |
DBID | NPM AAYXX CITATION 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S PIMPY PQEST PQQKQ PQUKI PRINS 5PM |
DOI | 10.7759/cureus.22804 |
DatabaseName | PubMed CrossRef ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China PubMed Central (Full Participant titles) |
DatabaseTitle | PubMed CrossRef Publicly Available Content Database ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest One Academic ProQuest Central (Alumni) |
DatabaseTitleList | Publicly Available Content Database PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X7 name: Health & Medical Collection url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2168-8184 |
ExternalDocumentID | 10_7759_cureus_22804 35382184 |
Genre | Case Reports |
GroupedDBID | 3V. 53G 5VS 7X7 8FI 8FJ ABUWG ADBBV ADRAZ AFKRA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS BCNDV BENPR BPHCQ BVXVI CCPQU FYUFA GROUPED_DOAJ HMCUK HYE KQ8 M48 NPM OK1 PGMZT PIMPY PQQKQ PROAC RPM UKHRP AAYXX CITATION 7XB 8FK AZQEC DWQXO K9. PQEST PQUKI PRINS 5PM |
ID | FETCH-LOGICAL-c309t-720540b4b9fc839e57949ede75c8ff897331ec96b60acd5e46222c1faea16ea93 |
IEDL.DBID | RPM |
ISSN | 2168-8184 |
IngestDate | Tue Sep 17 21:13:33 EDT 2024 Thu Oct 10 18:02:07 EDT 2024 Fri Aug 23 01:37:35 EDT 2024 Sat Sep 28 08:21:15 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | er-positive relapse-free interval breast cancer chronic disease late recurrence |
Language | English |
License | Copyright © 2022, Kamata et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c309t-720540b4b9fc839e57949ede75c8ff897331ec96b60acd5e46222c1faea16ea93 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976453/ |
PMID | 35382184 |
PQID | 2657633361 |
PQPubID | 2045583 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_8976453 proquest_journals_2657633361 crossref_primary_10_7759_cureus_22804 pubmed_primary_35382184 |
PublicationCentury | 2000 |
PublicationDate | 2022-03-03 |
PublicationDateYYYYMMDD | 2022-03-03 |
PublicationDate_xml | – month: 03 year: 2022 text: 2022-03-03 day: 03 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Palo Alto – name: Palo Alto (CA) |
PublicationTitle | Curēus (Palo Alto, CA) |
PublicationTitleAlternate | Cureus |
PublicationYear | 2022 |
Publisher | Cureus Inc Cureus |
Publisher_xml | – name: Cureus Inc – name: Cureus |
References | ref12 Banys M (ref7) 2012; 4 Takebayashi K (ref8) 2014; 39 Elfgen C (ref16) 2020; 15 (ref14) 1994; 271 Davies C (ref1) 2011; 378 von Minckwitz G (ref4) 2017; 377 Davies C (ref9) 2013; 381 Gerber LH (ref13) 2012; 118 van Maaren MC (ref5) 2019; 144 Nishimura R (ref10) 2013; 85 Baselga J (ref6) 2012; 366 Rosselli Del Turco M (ref15) 1994; 271 De Laurentiis M (ref2) 2008; 26 Colleoni M (ref11) 2016; 34 Moja L (ref3) 2012 |
References_xml | – volume: 381 year: 2013 ident: ref9 article-title: Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial publication-title: Lancet doi: 10.1016/S0140-6736(12)61963-1 contributor: fullname: Davies C – volume: 34 year: 2016 ident: ref11 article-title: Annual hazard rates of recurrence for breast cancer during 24 years of follow-up: results from the International Breast Cancer Study Group Trials I to V publication-title: J Clin Oncol doi: 10.1200/JCO.2015.62.3504 contributor: fullname: Colleoni M – volume: 366 year: 2012 ident: ref6 article-title: Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer publication-title: N Engl J Med doi: 10.1056/NEJMoa1113216 contributor: fullname: Baselga J – volume: 118 year: 2012 ident: ref13 article-title: Integrating a prospective surveillance model for rehabilitation into breast cancer survivorship care publication-title: Cancer doi: 10.1002/cncr.27472 contributor: fullname: Gerber LH – volume: 26 year: 2008 ident: ref2 article-title: Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials publication-title: J Clin Oncol doi: 10.1200/JCO.2007.11.3787 contributor: fullname: De Laurentiis M – volume: 144 year: 2019 ident: ref5 article-title: Ten-year recurrence rates for breast cancer subtypes in the Netherlands: a large population-based study publication-title: Int J Cancer doi: 10.1002/ijc.31914 contributor: fullname: van Maaren MC – volume: 39 year: 2014 ident: ref8 article-title: Breast cancer recurrence as peritoneal metastasis 42 years after total mastectomy publication-title: J Japanese Soc Surg doi: 10.4030/jjcs.39.870 contributor: fullname: Takebayashi K – volume: 4 year: 2012 ident: ref7 article-title: Dormancy in breast cancer publication-title: Breast Cancer (Dove Med Press) doi: 10.2147/BCTT.S26431 contributor: fullname: Banys M – volume: 378 year: 2011 ident: ref1 article-title: Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials publication-title: Lancet doi: 10.1016/S0140-6736(11)60993-8 contributor: fullname: Davies C – year: 2012 ident: ref3 article-title: Trastuzumab containing regimens for early breast cancer publication-title: Cochrane Database Syst Rev doi: 10.1002/14651858.CD006243.pub2 contributor: fullname: Moja L – volume: 271 year: 1994 ident: ref14 article-title: Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial. The GIVIO Investigators publication-title: JAMA doi: 10.1001/jama.1994.03510440047031 – volume: 15 year: 2020 ident: ref16 article-title: Metastatic breast cancer as a chronic disease: evidence-based data on a theoretical concept publication-title: Breast Care (Basel) doi: 10.1159/000502636 contributor: fullname: Elfgen C – volume: 271 year: 1994 ident: ref15 article-title: Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. National Research Council Project on Breast Cancer follow-up publication-title: JAMA doi: 10.1001/jama.271.20.1593 contributor: fullname: Rosselli Del Turco M – volume: 377 year: 2017 ident: ref4 article-title: Adjuvant pertuzumab and trastuzumab in early HER2-positive breast cancer publication-title: N Engl J Med doi: 10.1056/NEJMoa1703643 contributor: fullname: von Minckwitz G – volume: 85 year: 2013 ident: ref10 article-title: Evaluation of factors related to late recurrence--later than 10 years after the initial treatment--in primary breast cancer publication-title: Oncology doi: 10.1159/000353099 contributor: fullname: Nishimura R – ident: ref12 |
SSID | ssj0001072070 |
Score | 2.239197 |
Snippet | Although breast cancer treatments have made great strides in recent decades, there are still many recurrences. Late recurrence is one of the characteristics of... |
SourceID | pubmedcentral proquest crossref pubmed |
SourceType | Open Access Repository Aggregation Database Index Database |
StartPage | e22804 |
SubjectTerms | Breast cancer Cancer therapies Case reports Chemotherapy Dissection Drug therapy Endocrine therapy Epidermal growth factor Estrogens General Surgery Hospitals Internal Medicine Liver Lumpectomy Lymphatic system Mastectomy Medical imaging Metastasis Oncology Patients Pleural effusion Radiation therapy Surgery Tomography Tumors |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV05T8MwFLagSIgFcRMoyAOMoUl8xSwVV1UqyoAo6hY5jiO6pCVNB_49z0laCEiscWTLn4_3-Z0IXUgae1Ir5vJYSJemRrmhBCIXakqZUCFVygYnD595f0QHYzauFW7z2q1yeSeWF3Uy1VZH3gk4MGNCCPe7sw_XVo2y1tW6hMY62vADj1uXLjEW3zoWTwSwpSt_dyGY7OhFbhbzK5sDhjYl0R96-dtL8ofY6e2g7Zov4ptqgXfRmsn20Oawtojvo8GbyT_xEzBG_GJV52XwHp5k-NZ6mxf4zq5qfo0f580vWOE6Ly6-r2w03QM06j283vXduj6Cq4knCxcmB3wrprFMNfAcw-BsSZMYwXSYpqG05RiNljzmntIJM5QDGdB-qozyuVGSHKJWNs3MMcIBjSkIbl_FQKAUXIJEh4kHPZoECEoqHHS5xCqaVWkwIng-WEyjCtOoxNRB7SWQUX0YoGW1dA46qjBddUJgLPvKdJBooL36waa_brZkk_cyDTZMkFNGTv4f8hRtBTZiwbqNkTZqFfnCnAGPKOLzcrN8AUIsySM priority: 102 providerName: ProQuest – databaseName: Scholars Portal Open Access Journals dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT8IwFH9BTIwX47dTND3ocTjWrlu9EEUJEvFgxHBbutJFEjN1jET-e1_3QUSM121t099r936vfR8A54JFjlDSs3nkC5vFWtqBQCIXKMY8XwZMShOcPHjkvSHrj7xRDapqoyWA0z9NO1NPapi-Nb8-523c8Mhfm77viUs1S_Vs2jSJXdgarLsMbXTjxFcS_fy0xfFdXNyF5_tKo2WdtEI0f_tL_lBA3W3YKpkjuS5EvQM1nezCxqC8G9-D_otO5-QBuSN5MofoeRgfmSTkxvidZ6Rj5Jtekfvp8hMiSZkhl9wWtzXtfRh27547PbuslGAr6ojMxskh84pYJGKFjEd7uMuEHmvfU0EcB8IUZtRK8Ig7Uo09zTjSAtWKpZYtrqWgB1BP3hN9BMRlEUMV3pIRUimJv0OqgrGDPeoxUpXYt-Ciwir8KBJihGhIGEzDAtMwx9SCRgVkWEk1dDmaN5RS3rLgsMB00QnFsYy9aYG_hPbiA5MIe_lNMnnNE2LjBDnz6PH_Q57ApmtiF4wDGW1APUtn-hQZRRad5YvlGxwhzFI priority: 102 providerName: Scholars Portal |
Title | Very Late Recurrence in Breast Cancer: Is Breast Cancer a Chronic Disease? |
URI | https://www.ncbi.nlm.nih.gov/pubmed/35382184 https://www.proquest.com/docview/2657633361 https://pubmed.ncbi.nlm.nih.gov/PMC8976453 |
Volume | 14 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3PT8IwFH5RTIwX429RJD3ocbDRdl29GEGNGiHEiOG2tKWLJDINwsH_3tf9IKA3j1u3Zvv6mve99nuvAOeSaV8axb1QC-mxxCovkkjkIsMYFypiSrnk5G4vvB-wxyEfrgEvc2Ey0b7R40b6Pmmk47dMW_k5Mc1SJ9bsdzsR-lDGaXMd1tFAl0L0bGHFFy2041zkLgSXTTOf2vlXwxV-ccfwUJzjLrBZ9UR_6OVvleSS27nbge2CL5Lr_Lt2Yc2me7DZLXbE9-Hx1U6_yRMyRvLsls6z5D0yTknbqc1npONGdXpJHr5W7xBFirq45Cbfo7k6gMHd7Uvn3ivOR_AM9eXMw_9EvqWZlolBnmM5zi1pR1ZwEyUJgkRpYI0MdegrM-KWhUgGTJAoq4LQKkkPoZJ-pPYYSItpho47UBoJlEKAqIlGPvZoR0hQElGFixKr-DMvgxFj-ODgjXN44wzeKtRKIONiMmBLiEENpTQMqnCUY7ropByMKogVtBcPuPLXqy1oFVkZ7MIKTv795ilstVwyg1OU0RpUZtO5PUOKMdN1NKyhqMNG-7bXf8arLovqmZn9AC9J1Yk |
link.rule.ids | 230,315,730,783,787,888,2228,12068,21400,24330,27936,27937,31731,33756,43322,43817,53804,53806,74073,74630 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3LT8IwGP-imKgX41sUtQc9Tgbt2tULUZQAAgcDhtvSdV3kMpDHwf_er9tA0cTrurTpr4_v1-8JcCNZ6EqtPIeHQjosNsrxJRI5XzPmCeUzpWxwcrfHmwPWHnrDXOE2y90ql3dielFHY2115OUqR2ZMKeWV2uTDsVWjrHU1L6GxCVs2D5etYCCG4lvH4ooqbunM310IT5b1YmoWszubA4atS6I_9PK3l-QPsdPYh72cL5KHbIEPYMMkh7DdzS3iR9B-M9NP0kHGSF6t6jwN3iOjhDxab_M5qdtVnd6T1mz9C1Ekz4tLnjIbTe0YBo3nfr3p5PURHE1dOXdwcsi3QhbKWCPPMR6eLWkiIzztx7EvbTlGoyUPuat05BnGkQzoSqyMqnCjJD2BQjJOzBmQKgsZCu6KCpFAKbwEqfYjF3s0ERKUWBThdolVMMnSYAT4fLCYBhmmQYppEUpLIIP8MGDLaumKcJphuuqE4lj2lVkEsYb26geb_nq9JRm9p2mwcYKcefT8_yGvYafZ73aCTqv3cgG7VRu9YF3IaAkK8-nCXCKnmIdX6cb5AsuyzAo |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LTwIxEJ4oJsaL8S0-e9DjykK77daLEYGAAjFEDLdNt9uNXBblcfDfO2ULiiZet5s2_dpOv7bfzABcSRb7UqvA47GQHkuN8kKJRC7UjAVChUwp65zc6fJmnz0OgoHTP02crHJhE-eGOhlpe0deqnBkxpRSXi6lThbxXGvcvX94NoOUfWl16TTWYUMwTv0CbFTr3efe942LLyo4wXP1uxCBLOnZ2MwmNzYiDFvdl_6Qzd-ayR-bUGMHth17JPf5cO_Cmsn2YLPj3sf34fHVjD9JG_kj6dmL9LkrHxlmpGq151PyYMd4fEtak9UvRBEXJZfU8hebuwPoN-ovD03PZUvwNPXl1MPOIfuKWSxTjazHBLjSpEmMCHSYpqG0yRmNljzmvtJJYBhHaqDLqTKqzI2S9BAK2Sgzx0AqLGa4jZdVjHRKoUmkOkx8rNEkSFdSUYTrBVbRex4UI8LDhMU0yjGN5pgW4WwBZOSWBpYsB7IIRzmmy0ootmXPnEUQK2gvf7DBsFdLsuHbPCg2dpCzgJ783-QlbOKsidqt7tMpbFWsK4PVk9EzKEzHM3OOBGMaX7iZ8wWlcdGn |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Very+Late+Recurrence+in+Breast+Cancer%3A+Is+Breast+Cancer+a+Chronic+Disease%3F&rft.jtitle=Cur%C4%93us+%28Palo+Alto%2C+CA%29&rft.au=Kamata+Arimichi&rft.au=Hino+Koji&rft.au=Kamiyama+Koki&rft.au=Takasaka+Yoshihiro&rft.date=2022-03-03&rft.pub=Cureus+Inc&rft.eissn=2168-8184&rft.volume=14&rft.issue=3&rft_id=info:doi/10.7759%2Fcureus.22804&rft.externalDBID=HAS_PDF_LINK |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2168-8184&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2168-8184&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2168-8184&client=summon |